Concurrent Obesity, Diabetes, and Steatosis Increase Risk of Advanced Fibrosis Among HCV Patients: A Systematic Review

被引:50
作者
Dyal, Harleen K. [1 ]
Aguilar, Maria [1 ]
Bhuket, Taft [1 ]
Liu, Benny [1 ]
Holt, Edward W. [2 ]
Torres, Sharon [1 ]
Cheung, Ramsey [3 ,4 ]
Wong, Robert J. [1 ,5 ]
机构
[1] Alameda Hlth Syst, Highland Hosp, Div Gastroenterol & Hepatol, Endoscopy Unit, Oakland, CA 94602 USA
[2] Calif Pacific Med Ctr, Div Hepatol, Dept Transplantat, San Francisco, CA 94115 USA
[3] Stanford Univ, Div Gastroenterol & Hepatol, Sch Med, Stanford, CA 94305 USA
[4] Vet Affairs Palo Alto Hlth Care Syst, Div Gastroenterol & Hepatol, Palo Alto, CA USA
[5] Univ Calif San Francisco, San Francisco, CA 94143 USA
关键词
Body mass index; Metabolic syndrome; Nonalcoholic steatohepatitis; Fibrosis; CHRONIC HEPATITIS-C; FATTY LIVER-DISEASE; INSULIN-RESISTANCE; HEPATOCELLULAR-CARCINOMA; LARGE-COHORT; GENOTYPE; PROGRESSION; INFECTION; VIRUS; CIRRHOSIS;
D O I
10.1007/s10620-015-3760-3
中图分类号
R57 [消化系及腹部疾病];
学科分类号
100201 [内科学];
摘要
Rising rates of obesity, diabetes mellitus (DM), and nonalcoholic fatty liver disease among patients with chronic hepatitis C virus infection (HCV) may contribute to more rapid disease progression. To evaluate the impact of concurrent obesity, DM, and steatosis on disease progression among HCV patients. A systematic review using structured keyword search of MEDLINE and EMBASE from January 1, 2001, to July 1, 2014, was performed to identify original articles evaluating the association of obesity, DM, and steatosis with advanced fibrosis (AF) among adults with chronic HCV. Studies involving HCV patients coinfected with human immunodeficiency virus, hepatitis B virus, hepatocellular carcinoma, or other chronic liver diseases were excluded. Quality assessment utilized Newcastle-Ottawa Scale. Twenty cohort studies met inclusion criteria for analyses. Obesity was associated with increased risk of AF in seven studies with effect size ranging from OR 1.08 to 7.69. However, four studies did not demonstrate a significant association between obesity and AF. The presence of advanced steatosis among HCV patients was associated with increased risk of AF in 12 studies (OR 1.80-14.3). Concurrent DM was associated with increased risk of AF in six studies (OR 2.25-9.24). Thirteen studies were good quality, and seven studies were fair quality. Concurrent DM and steatosis are associated with increased risk of AF among chronic HCV patients. The majority of studies demonstrated significant associations of obesity with AF. Targeted interventions to optimize management of obesity-related diseases among HCV patients may help mitigate HCV disease progression.
引用
收藏
页码:2813 / 2824
页数:12
相关论文
共 36 条
[1]
A multivariable model of clinical variables predicts advanced fibrosis in chronic hepatitis C [J].
Alsatie, Mazen ;
Kwo, Paul Y. ;
Gingerich, Joel R. ;
Qi, Rong ;
Eckert, George ;
Cummings, Oscar W. ;
Imperiale, Thomas F. .
JOURNAL OF CLINICAL GASTROENTEROLOGY, 2007, 41 (04) :416-421
[2]
Bhat Ganesh, 2013, Trop Gastroenterol, V34, P18
[3]
Worsening of steatosis is an independent factor of fibrosis progression in untreated patients with chronic hepatitis C and paired liver biopsies [J].
Castéra, L ;
Hézode, C ;
Roudot-Thoraval, F ;
Bastie, A ;
Zafrani, ES ;
Pawlotsky, JM ;
Dhumeaux, D .
GUT, 2003, 52 (02) :288-292
[4]
The impact of hepatic steatosis on the natural history of chronic hepatitis C infection [J].
Cross, T. J. S. ;
Quaglia, A. ;
Hughes, S. ;
Joshi, D. ;
Harrison, P. M. .
JOURNAL OF VIRAL HEPATITIS, 2009, 16 (07) :492-499
[5]
Insulin resistance: a major factor associated with significant liver fibrosis in Egyptian patients with genotype 4 chronic hepatitis C [J].
El Ray, Ahmed ;
Asselah, Tarik ;
Moucari, Rami ;
El Ghannam, Maged ;
Taha, Alaa A. ;
Saber, Mohamed A. ;
Akl, Maha ;
Atta, Raafat ;
Shemis, Mohamed ;
Radwan, Azza S. ;
Ghali, Ayman ;
Paradis, Valerie ;
Marcellin, Patrick .
EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 2013, 25 (04) :421-427
[6]
Weight-Related Effects on Disease Progression in the Hepatitis C Antiviral Long-Term Treatment Against Cirrhosis Trial [J].
Everhart, James E. ;
Lok, Anna S. ;
Kim, Hae-Young ;
Morgan, Timothy R. ;
Lindsay, Karen L. ;
Chung, Raymond T. ;
Bonkovsky, Herbert L. ;
Ghany, Marc G. .
GASTROENTEROLOGY, 2009, 137 (02) :549-557
[8]
Insulin resistance is a cause of steatosis and fibrosis progression in chronic hepatitis C [J].
Fartoux, L ;
Poujol-Robert, A ;
Guéchot, J ;
Wendum, D ;
Poupon, R ;
Serfaty, L .
GUT, 2005, 54 (07) :1003-1008
[9]
Is Genotype 3 of the Hepatitis C Virus the New Villain? [J].
Goossens, Nicolas ;
Negro, Francesco .
HEPATOLOGY, 2014, 59 (06) :2403-2412
[10]
Nonalcoholic fatty liver disease: A comprehensive review of a growing epidemic [J].
Hassan, Kareem ;
Bhalla, Varun ;
El Regal, Mohammed Ezz ;
A-Kader, H. Hesham .
WORLD JOURNAL OF GASTROENTEROLOGY, 2014, 20 (34) :12082-12101